Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 110 of the 115 references it cites were found in a registry or an index; 22 of the 65 sources its claims cite were checked for support.
Abstract
Insulin resistance is a characteristic feature of type 2 diabetes and plays a major role in the pathogenesis of the disease (1,2). Although �-cell failure is the sine qua non for development of type 2 diabetes, skeletal muscle insulin resistance is considered to be the initiating or primary defect that is evident decades before �-cell failure and overt hyperglycemia develops (3,4). Insulin resistance is defined as a reduced response of target tissues (compared with subjects with normal glucose tolerance [NGT] without a family history of diabetes), such as the skeletal muscle, liver, and adipocytes, to
Overview
CoChat Summary
TL;DR
This review argues that skeletal muscle insulin resistance—especially impaired glycogen synthesis—is the initiating/primary defect in most type 2 diabetes, preceding β-cell failure and overt hyperglycemia. It concludes that overt diabetes requires β-cell failure to supervene, while muscle insulin resistance is already evident in normal glucose-tolerant high-risk relatives and prospective populations.
Key findings
- Skeletal muscle is the predominant site of insulin-mediated postprandial glucose uptake: under euglycemic hyperinsulinemia, ∼80% of glucose uptake occurs in skeletal muscle; leg muscle glucose uptake plateaus at ∼10 mg/kg leg weight per minute after 60 min, and in lean type 2 diabetic subjects it is reduced by ∼50% during the last hour of the insulin clamp.
- In lean NGT offspring of two type 2 diabetic parents, a two-step euglycemic clamp (20 and 40 mU/m² per min; plasma insulin ∼40 and ∼80 μU/ml) showed glucose uptake decreased by 33% and 43%, respectively; the impairment was accounted for entirely by reduced nonoxidative glucose metabolism/glycogen synthesis, with no defect in insulin suppression of hepatic glucose production.
- Prospective Pima Indian data showed both progressors and nonprogressors had a further 11–14% reduction in insulin sensitivity; nonprogressors increased insulin secretion by 30%, whereas progression to type 2 diabetes was associated with a 78% decline in the acute insulin response to intravenous glucose.
- Hyperinsulinemia itself worsens muscle insulin resistance: a 72 pmol/l (11 μU/ml) increase in plasma insulin for 72–96 h reduced insulin-stimulated glucose disposal by 30–40%, entirely via impaired nonoxidative glucose disposal; in rats, 7-day hyperinsulinemia reduced total-body glucose uptake, storage, and glycolysis by 39%, 62%, and 26%. Mitochondrial ATP production increased by 90% in NGT subjects without family history but only 5% in insulin-resistant offspring.
Methods
- Narrative review/symposium article; no primary study design or new sample. It synthesizes human studies using the euglycemic insulin clamp (described as the gold standard), indirect calorimetry, muscle biopsy, femoral/forearm catheterization, PET, NMR spectroscopy, OGTT, and prospective follow-up.
- Populations discussed include lean NGT first-degree relatives/offspring of two type 2 diabetic parents, Mexican Americans, Pima Indians, Caucasians in San Antonio, and type 2 diabetic subjects. Main analysis is qualitative synthesis of cited evidence.
Limitations
- Stated: by the time hyperglycemia is manifest, multiple abnormalities (elevated glucose, FFA, and cytokines) coexist, making it extremely difficult to separate each defect’s contribution; at initial presentation it is not possible to define which defect came first.
- Stated: it is unclear whether mitochondrial dysfunction leads to increased intramyocellular lipid and insulin resistance or increased muscle lipid leads to mitochondrial dysfunction and insulin resistance (“which is the cart and which is the horse”).
- Evident: as a narrative review, it lacks systematic search, formal quality assessment, or meta-analysis; conclusions depend on selected cited studies, and several figures are in an online appendix rather than the text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
14 Valid · 1 Not valid · 22 Not checked · 11 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In type 2 diabetes, impaired glycogen synthesis secondary to reduced glycogen synthase activity is the earliest detectable metabolic defect ( 39 – 41 ).”
What the sources say
- Not matchedcites [39] DeFronzo, 1997, Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying genes, Diabetes Rev
We searched by its title and found no matching paper.
- Partly supportedcites [40] Bogardus, 1984, Correlation between muscle glycogen synthase activity and in vivo insulin action in man, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports a correlation between muscle glycogen synthase activity and insulin-mediated glucose storage in glucose-tolerant and diabetic subjects. It hypothesizes a link between reduced enzyme activity and impaired glucose handling, but does not establish that one causes the other or that impaired glycogen synthesis is the earliest detectable metabolic defect in type 2 diabetes. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [41] Shulman, 1990, Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy, N Engl J Med source
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Maintaining the integrity of the IRS-1/PI-3 kinase/Akt pathway is essential for normal insulin-mediated glucose uptake in skeletal muscle ( 26 ).”
What the sources say
- Partly supportedcites [26] Krook, 2000, Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients, Diabetes sourceExperimental — accuracy not yet measured
The paper’s introduction identifies IRS-1 and PI 3-kinase as components of insulin signaling involved in skeletal-muscle glucose transport. Its study summary says reduced PI 3-kinase activity may partly account for reduced insulin-stimulated glucose transport, while additional defects contribute. The cited passages do not establish a role for Akt or show that integrity of the entire pathway is essential for normal uptake. (LLM, conf=0.88)
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Multiple investigators unequivocally have demonstrated that lean NGT offspring of two parents with type 2 diabetes exhibit moderate to severe skeletal muscle insulin resistance ( 28 – 33 ).”
What the sources say
- Not checked — no full text of the sourcecites [28] Perseghin, 1997, Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study, Diabetes source
- Not checked — no full text of the sourcecites [29] Ferrannini, 2003, Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis, J Clin Endocrinol Metab source
- Not checked — no full text of the sourcecites [30] Kashyap, 2004, Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes, Am J Physiol Endocrinol Metab source
- Partly supportedcites [31] Vaag, 1992, Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus, J Clin Invest sourceExperimental — accuracy not yet measured
The Subjects section says the participants were nonobese, had normal oral glucose tolerance, and had at least one parent with NIDDM—not necessarily two. The Discussion reports skeletal-muscle insulin resistance but also considerable overlap with controls; it does not establish moderate-to-severe resistance in offspring of two affected parents. Page numbers are unavailable in our copy. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [32] Gulli, 1992, The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents, Diabetes source
- Not checked — no full text of the sourcecites [33] Tripathy, 2003, Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetic proband, Am J Physiol source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“In lean insulin-resistant NGT offspring of type 2 diabetic parents, increased serine phosphorylation of IRS-1 in skeletal muscle has been documented in association with impaired activation of Akt ( 57 ) (Fig. A11).”
What the sources say
- Supportedcites [57] Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest source
The Introduction describes the offspring as young, lean, normoglycemic, and insulin-resistant. The Results report increased IRS-1 serine phosphorylation and reduced insulin-stimulated Akt phosphorylation in the offspring, and the Discussion explicitly describes these findings as associated. Page numbers are not provided in our copy. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This observation is of important clinical significance, since diacylglycerol, long-chain fatty acyl CoAs, and ceramides all have been shown to cause serine phosphorylation of insulin resistance and IRS-1 and lead to the development of insulin resistance in skeletal muscle ( 59 , 60 ).”
What the sources say
- Not checked — no full text of the sourcecites [59] Hotamisligil, 1996, IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance, Science source
- Partly supportedcites [60] Jiang, 1999, Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion says elevated free fatty acids may impair insulin’s metabolic action and notes protein kinase C activation in skeletal muscle. It does not say that diacylglycerol, long-chain fatty acyl CoAs, or ceramides cause IRS-1 serine phosphorylation and thereby produce skeletal-muscle insulin resistance; its serine-phosphorylation discussion concerns the insulin receptor instead. Page numbers are unavailable in our copy. (LLM, conf=0.83)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
21 more claims · 6 with their cited sources checked
Create a free account to see all 48 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 4
- It may state two separate claims as one. 20
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Various epidemiological and experimental studies have shown that muscle weakness, decreased muscle mass, reduced activation of glycogen synthase, and alterations in the numbers of glycolytic skeletal muscle fibers are related to, and may precede, insulin resistance, glucose intolerance, and T2D [332,333].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [333]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Even though pancreatic beta cell dysfunction is the main pathogenesis of type 2 diabetes mellitus, given that the uptake of postprandial glucose by skeletal muscles is approximately 80–90%, skeletal muscle IR plays a crucial role in the development and progression of diabetes mellitus [129,130].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [130]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dysregulation of these processes contributes to the pathogenesis of numerous diseases, including diabetes and obesity (DeFronzo and Tripathy, 2009; Sugden et al., 2009), mitochondrial disorders (Kerr, 2013), cardiac failure (Fillmore and Lopaschuk, 2013), neurodegenerative disorders (Cunnane et al., 2011; Yao et al., 2011), and cancer (Currie et al., 2013; Tennant et al., 2010).”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as DeFronzo and Tripathy, 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, the SM accounts for >80% of glucose uptake in the post-prandial period following an oral glucose load, with linear increases in uptake over time [17,20].”
From Optimised Skeletal Muscle Mass as a Key Strategy for Obesity Management (2025) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Skeletal muscle is the main tissue responsible for insulin-stimulated glucose disposal and an impaired uptake is common in obesity and has substantial impact on whole-body glucose turnover.8,9”
From Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies (2024) · cites this paper as [8]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 1×
“RESEARCH DESIGN AND METHODS — The euglycemic insulin clamp technique (5) is considered to be the gold standard for measuring insulin action in vivo.”
BackgroundSelf-citationMatsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621 · cited 1×
“70) with insulin sensitivity measured with the euglycemic insulin clamp (9).”
MethodSelf-citationKatz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760 · cited 1×
“This results in activation of downstream protein kinase B (also called Akt) and phosphorylation of Akt substrate 160 (AS160), which facilitates the translocation of GLUT4 to the sarcolemma and subsequent entry of glucose into the cell (25).”
BackgroundHotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456 · cited 7×
“Because the majority of type 2 diabetic subjects are obese, they also have daylong elevation of the plasma free fatty acid (FFA) concentration and increased circulating levels of inflammatory cytokines (1,2).”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 2
- Pendergrass, 2007, Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals, Am J Physiol Endocrinol Metab, 292, E92, 10.1152/ajpendo.00617.2005 · DOI · Paper page
- Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest, 115, 3587, 10.1172/jci25151 · DOI · Paper page
Cited by
Items 1,801–1,900 of 2,099
A Role for TNMD in Adipocyte Differentiation and Adipose Tissue Function: A Dissertation
Senol-Cosar, O. (2016) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2pc7s · Cited by 1
“Muscle, on the other hand, is the biggest contributor to insulin-stimulated glucose uptake and can synthesize glycogen after feeding (269, 270).”
BackgroundThe Effects of Interleukin-10 on Skeletal Muscle Insulin Resistance and Myogenesis
Dağdeviren, S. (2016) · eScholarship@UMassChan · doi:10.13028/m2qp42 · Cited by 1
“Akt also phosphorylates forkhead box O (FOXO) proteins and decreases the transcription of ubiquitin ligases like MAFbx and MURF-1[120].”
BackgroundDietary polyphenols: modulators of energy and substrate metabolism in obese humans
Most, J. (2016) · Research Publications (Maastricht University) · doi:10.26481/dis.20160115jm
Czajkowski, S. (2015) · TSpace (University of Toronto) · doi:10.13140/rg.2.2.15202.27845
Stem Cell Therapy in Muscle Degeneration
Duelen, R., Costamagna, D., & Sampaolesi, M. (2017) · Springer eBooks · doi:10.1007/978-981-10-3292-9_3
Duncan, A. (2016) · Research Portal (King's College London) · Cited by 1
Santaren, I. D. (2014) · TSpace (University of Toronto) · Cited by 1
Mukherjee, S., & Chen, S. (2017) · CRC Press eBooks · doi:10.1201/b21629-7
Queiroz, A. L. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2017.tde-30032017-162044 · Cited by 1
Loyd, C. (2014) · OhioLink ETD Center (Ohio Library and Information Network)
Lavrador, M. S. F. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2017.tde-13062017-164736
The Role of SIRT1 in Pancreatic Beta Cells
Luu, L. (2013) · TSpace (University of Toronto)
Protein Phosphatase 2a Interactions In Islet And Human Skeletal Muscle In Diabetes
Damacharla, D. (2017) · Human Biology
Protein Phosphatase 2a Function And Regulation In Insulin Resistant Human Skeletal Muscle Cells
Sulaiman, S. (2017) · Human Biology
Exercise, Protein and Vitamin D for Type 2 Diabetes Mellitus
Miller, E. G. (2017) · Figshare
La voie ASP-C5L2 : un pont entre l'homéostasie métabolique et l'inflammation
Fisette, A. (2013) · Corpus Université Laval (Université Laval)
Ranasinghe, D. C. (2018) · Queensland University of Technology · doi:10.5204/thesis.eprints.115457
Investigating the Role of the Vascular Endothelium in Insulin Delivery
Tokarz, V. L., Gao, Y. K., Sugiyama, M. G., Klip, A., & Lee, W. (2017) · The FASEB Journal · doi:10.1096/fasebj.31.1_supplement.883.12
Rees, J. (2017) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3tq5rt66
Immune cell phenotype and function : impact of type 2 diabetes, obesity, and exercise
Barry, J. (2018) · cIRcle (University of British Columbia) · doi:10.14288/1.0362080
“Insulin resistance in the muscle is believed to be the primary defect in T2D [52] contributing to postprandial hyperglycemia.”
BackgroundPriyanka, E. (2014) · YorkSpace (York University)
The Immediate and Extended Effect of Diet and Exercise on Metabolic Flexibility
Allerton, T. D. (2017) · Louisiana State University · doi:10.31390/gradschool_dissertations.4493
Síndrome metabólica e declínio cognitivo: papel do exercício físico
Gonçalves, N. G. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2018.tde-11092018-153547
Doddigarla, Z. (2018) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v6i11.72
“To the third group to determine the effect of melatonin in the development of IR, T2DM, and magnesium status of the animals, thus, these animals received unlimited HSD and melatonin of 200 μg/animal/day until the end of the study.”
BackgroundInfluentialPrediabetic state and dyslipidemia in freshmen in Health Sciences campus of a Mexican University
Ascencio, A. P. G., Hernández, J. A. C., Guzmán‐Priego, C. G., & Cano, J. M. M. (2018) · Archivos de Medicina (Manizales) · doi:10.30554/archmed.18.2.2777.2018
Oghagbon, E. K. (2018) · Journal of BioMedical Research and Clinical Practice · doi:10.46912/jbrcp.v1.i2.2018.55 · Cited by 2
Castrillón, J. J. C. (1969) · Archivos de Medicina (Manizales) · doi:10.30554/archmed.18.2.3061.2018
An exploration into the proteins that regulate skeletal muscle lipid metabolism
Whytock, K. L. (2021) · Liverpool John Moores University · doi:10.24377/ljmu.t.00009962 · Cited by 2
Nutraceuticals for Diabetes in Dogs and Cats
Gupta, R. C., Lall, R., Sinha, A., & Srivastava, A. (2019) · Springer eBooks · doi:10.1007/978-3-030-04624-8_35 · Cited by 2
Insulin sensitivity is mediated by glucose in the hepatoportal region in the rat
Johnson, H. M. (2017) · The Sydney eScholarship Repository (The University of Sydney)
The Association of COPD Exacerbations with New Onset Type 2 Diabetes among Medicare Patients
Marino, J. S., Ruban, C., & Blanchette, C. M. (2017) · Journal of health economics and outcomes research · doi:10.36469/9810
Glucocorticoid Action in the Mediobasal Hypothalamus Regulates Glucose Production In Vivo
Beaulieu-Bayne, E. (2019) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-eahb-a894
Does The Timing of Exercise Affect Glucose Concentrations in Individuals with Type 2 Diabetes?
Munan, M. J. (2019) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-m7rg-h753
Post-weaning metabolic programming by dietary monosaccharides
Bouwman, L. M. S. (2019) · doi:10.18174/495333
Novel clinico-molecular insights into the role of bisphenol-A (BPA) in the etiology of diabetes
Soundararajan, A. (2019) · Own your potential (DEAKIN)
Helsel, P. J. (2020) · VTechWorks (Virginia Tech)
Skeletal muscle composition in various breeds of domestic dogs: (A comparative study)
van Boom, K. M. (2019) · Open University of Cape Town (University of Cape Town)
Novel inhibitors of lipid phosphatase SHIP2 and their effects on the phosphorylation of Akt kinase
Mehta, S. (2020) · Helda - University of Helsinki Institutional Repository
Farooqui, A. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819603-8.00010-9
Yamagiwa, T., Yu, Y., Inoue, Y., Belov, V., Papisov, M. I., Inokuchi, S., Kaneki, M., White, M. F., Fischman, A. J., & Tompkins, R. G. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2004.09639
“These findings suggest that impaired insulin-stimulated Rd in skeletal muscle, not elevated HGP, plays a role in the development of burn-induced insulin resistance in a mouse model.”
BackgroundInfluentialChetina, E. V., Markova, G. A., & Sharapova, E. P. (2020) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750820020043
Association of Serum Creatinine Levels and Risk of Type 2 Diabetes Mellitus in KoreaPreprint
Song, D. K., Lee, H.-J., Hong, Y. S., & Sung, Y. (2020) · Research Square · doi:10.21203/rs.3.rs-127616/v1
Oliveira, D. S. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2020.tde-31102020-153052
GLP-1R Agonists & Cardiac Energy Metabolism in Type 2 Diabetes
Almutairi, M. G. (2019) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-fhr3-cr50
Unlocking innate healing potentials in patients with type 2 diabetes
Wu, L., & Yang, S.-N. (2020) · General Internal Medicine and Clinical Innovations · doi:10.15761/gimci.1000189
“Impairments in the adipose tissue, skeletal muscle, liver, brain and microvasculature significantly contribute to aberrant glucose metabolism in T2D [9,10,19-22] (Figure 1).”
Background(2020) · International Journal of Biology Pharmacy and Allied Sciences · doi:10.31032/ijbpas/2020/9.3.4976
Nutraceuticals for diabetes and glucose balance
Gupta, R. C., Doss, R. B., Garg, R. C., Lall, R., Srivastava, A., & Sinha, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821038-3.00006-9 · Cited by 5
Ancu, O., Naufahu, J., Barclay, R. D., Peter, W., & Mackenzie, R. (2021) · Clinical Diabetes and Research · doi:10.36959/647/495 · Cited by 1
“Research has consistently shown that defects in insulin signaling and insulin-mediated glucose uptake in skeletal muscle contribute to whole body hyperglycemia [3-10].”
BackgroundRocha, D. S., & Kucharski, L. C. (2021) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2020-0079
Utilizing Temporal Information in The EHR for Developing a Novel Continuous Prediction Model
Hsieh, K. (2019) · Digital Commons-TMC (Texas Medical Center)
Oyebode, O. A., Erukainure, O. L., Mopuri, R., Sanni, O., Koorbanally, N. A., & Islam, M. S. (2021) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2021.1899240
Relationship between skeletal muscle mass with metabolic syndrome in Chinese eldersPreprint
Yang, T., Guo, X., Wang, C., Zhao, T., & Li, D. (2021) · Research Square · doi:10.21203/rs.3.rs-428604/v1
Bhalerao, S. S., Kharche, J. S., & Harke, S. (2021) · Research Square · doi:10.21203/rs.3.rs-181905/v1
van Polanen, N. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210922np
Cardiovascular Health in Professional Rugby Union Athletes
McHugh, C. (2021) · Arrow@dit (Dublin Institute of Technology)
Zong, J., Tang, Y., Wang, T., Ullah, I., Xu, K., Wang, J., Chen, P., Chen, Z., Zhu, T., Chen, J., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-1100332/v1
“Patients who met any of the following criteria were excluded: (1) allergic or intolerant to aspirin or clopidogrel; (2) at high risk of bleeding (e.”
BackgroundSitagliptin ameliorates the insulin sensitivity in Skeletal Muscles of Metabolic Syndrome Rat Model
(2021) · Current Science International · doi:10.36632/csi/2021.10.4.52
iPSCs in insulin resistance, type 2 diabetes, and the metabolic syndrome
Carcamo‐Orive, I. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99892-5.00020-7
Novel aspects of exercise training to promote human metabolic health
Mancilla, R. (2022) · Research Publications (Maastricht University) · doi:10.26481/dis.20220210rm
Linking Inflammation, Obesity, and Diabetes
McArdle, M. A., Kennedy, E. B., & Roche, H. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-11251-0_29 · Cited by 2
Linking Inflammation, Obesity and Diabetes
McArdle, M. A., Kennedy, E. B., & Roche, H. M. (2015) · Springer eBooks · doi:10.1007/978-3-319-12125-3_29-1
“Skeletal muscle is the main site for glucose uptake in the body, andmuscle IR represents a core defect in T2D (DeFronzo and Tripathy 2009).”
BackgroundGrundy, S. M. (2018) · Endocrinology · doi:10.1007/978-3-319-27316-7_3-1 · Cited by 1
Marcella, B. M., Hockey, B. L., Braun, J. L., Whitley, K. C., Geromella, M. S., Baranowski, R. W., Watson, C. J. F., Silvera, S., Hamstra, S. I., Wasilewicz, L. J., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.16.480726
Saikia, D., & Kumar, S. (2022) · Medical Hypotheses · doi:10.1016/j.mehy.2022.110804
Kwon, S. H., Oh, E., Cho, N., Kang, H., Kim, S. H., & Park, H. K. (2022) · Research Square · doi:10.21203/rs.3.rs-1552951/v1
Impact of gut-derived metabollites on substrate metabolism and metabolic health
Gonzalez Hernandez Manuel, A. (2020) · Research Publications (Maastricht University) · doi:10.26481/dis.20201027mgh
Mukherjee, S., & Chen, S.-B. (2017) · CRC Press eBooks · doi:10.1201/9781315402185-8
Wang, X., Chen, Z., Yang, F., Ding, X., Cao, C., Hu, H., & Zou, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-360026/v1
“It is one of the main parts of insulin-mediated glucose uptake, especially postprandial glucose[36].”
BackgroundPierre-Jerome, C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99352-4.00020-6
Ye, C., Kong, L., Wang, Y., Xu, M., Zheng, J., Xu, Y., Li, M., Zhao, Z., Lu, J., Chen, Y., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4196965
Pettit‐Mee, R. J. (2022) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/91682
Spagnol, A. R. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.42.2022.tde-16112022-160054
Improving flexibility in substrate metabolism: a pharmacological and lifestyle approach
Veelen, A. (2022) · Research Publications (Maastricht University) · doi:10.26481/dis.20230125av
Silva, T. D. O. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2020.tde-07012021-141219
Association Of Homa-Ir Value With Relative Handgrip Strength In Adult Women In Jakarta
Kurniawan, A. R., Witjaksono, F., & Prafiantini, E. (2023) · Asian Journal of Healthy and Science · doi:10.58631/ajhs.v3i1.21
Bamba, B., Silué, S., Atayi, T. E., & Tako, A. N. (2023) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2023.115006
Pantothenate Kinase 4 controls efficient skeletal muscle energy substrate metabolism via acetyl-CoAPreprint
Miranda‐Cervantes, A., Fritzen, A. M., Raun, S. H., Hodek, O., Møller, L. L. V., Johann, K., Deisen, L., Gregorevic, P., Gudiksen, A., Artati, A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.14.551603
Vanweert, F. (2023) · Research Publications (Maastricht University) · doi:10.26481/dis.20231117fv · Cited by 1
Mi, F. H. H., Sadashiva, C. T., Benny, N., et al. (2023) · International Journal of Pharmacology · doi:10.3923/ijp.2023.730.739
Santos, B. C. F. (2022) · doi:10.47749/t/unicamp.2022.1263751 · Cited by 1
Liu, C., tao, X., Niu, R., Lü, W., Zeng, X., & Sun, X. (2023) · Research Square · doi:10.21203/rs.3.rs-3635355/v1
Harmsen, J. (2023) · Research Publications (Maastricht University) · doi:10.26481/dis.20231213jh
Syndromes of severe insulin resistance: lessons from nature
Krentz, A. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91707-0.00005-x
Maharini, F. S., Sansuwito, T. B., & Sunarti, S. (2024) · International Journal of Advancement in Life Sciences Research · doi:10.31632/ijalsr.2024.v07i01.008
Jayavel, A., Shivasekar, M., & Vinodhini, V. M. (2023) · International Journal of Kinesiology and Sports Science · doi:10.7575/aiac.ijkss.v.11n.4p.17
İnsülin 100 Yıllık Mucize Hormon
Cerit, E. T., Barlas, T., Atalar, K., Bahçelioğlu, M., Kaplanoğlu, G. T., Seymen, C. M., Erdem, H. B., Ergün, M. A., Demir, Ö., Gülbahar, Ö., et al. (2022) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.871
Metadata
- Authors
- DeFronzo, R. A., & Tripathy, D.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Tripathy, Devjit
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- suppl_2
- Pages
- S157-S163
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2811436
- OpenAlex
- W2170869159
- Cited by
- 2,102
- References
- 115
- Citations by year
- 2026: 149 · 2025: 188 · 2024: 187 · 2023: 161 · 2022: 200 · 2021: 199 · 2020: 161 · 2019: 146 · 2018: 166 · 2017: 132 · 2016: 119 · 2015: 99 · 2014: 72 · 2013: 54 · 2012: 29
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- skeletal muscle insulin resistance, type 2 diabetes, insulin resistance, beta-cell failure, type 2 diabetes pathogenesis, glucose tolerance, hyperglycemia
- MeSH terms
- Insulin Secretion, Blood Glucose, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Homeostasis, Humans, Insulin, Insulin Resistance, Glucose Clamp Technique, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.